Drug–drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation

D Sychev, K Mirzaev, M Cherniaeva… - Drug metabolism and …, 2020 - degruyter.com
Objectives For revealing the peculiarities of the drug–drug interaction of rivaroxaban
(substrate CYP3A4 and P-gp) and calcium channel blockers (CCBs)(verapamil–inhibitor …
被引用次数：14 相关文章

Drug–drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation

D Sychev, K Mirzaev, M Cherniaeva, M Kulikova… - 2020 - degruyter.com
Objectives: For revealing the peculiarities of the drug–drug interaction of rivaroxaban
(substrate CYP3A4 and P-gp) and calcium channel blockers (CCBs)(verapamil–inhibitor …

Drug–drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation

D Sychev, K Mirzaev, M Cherniaeva… - Drug Metabolism …, 2020 - search.proquest.com
For revealing the peculiarities of the drug–drug interaction of rivaroxaban (substrate
CYP3A4 and P-gp) and calcium channel blockers (CCBs)(verapamil–inhibitor CYP3A4 and …

[引用][C] Drug-drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation

D Sychev, M Kulikova, O Golovina, D Bahteeva… - Drug Metabolism and …, 2020 - elibrary.ru

Drug–drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation.

D Sychev, K Mirzaev, M Cherniaeva… - Drug Metabolism & …, 2020 - search.ebscohost.com
Objectives: For revealing the peculiarities of the drug–drug interaction of rivaroxaban
(substrate CYP3A4 and P-gp) and calcium channel blockers (CCBs)(verapamil–inhibitor …

Drug-drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation.

D Sychev, K Mirzaev, M Cherniaeva… - Drug Metabolism and …, 2020 - europepmc.org
Objectives For revealing the peculiarities of the drug-drug interaction of rivaroxaban
(substrate CYP3A4 and P-gp) and calcium channel blockers (CCBs)(verapamil-inhibitor …

Drug-drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation

D Sychev, K Mirzaev, M Cherniaeva… - Drug metabolism …, 2020 - pubmed.ncbi.nlm.nih.gov
Objectives For revealing the peculiarities of the drug-drug interaction of rivaroxaban
(substrate CYP3A4 and P-gp) and calcium channel blockers (CCBs)(verapamil-inhibitor …

Drug-drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation.

D Sychev, K Mirzaev, M Cherniaeva… - Drug Metabolism and …, 2020 - europepmc.org
Objectives For revealing the peculiarities of the drug-drug interaction of rivaroxaban
(substrate CYP3A4 and P-gp) and calcium channel blockers (CCBs)(verapamil-inhibitor …

Drug-drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation

D Sychev, K Mirzaev, M Cherniaeva… - Drug metabolism … - pubmed.ncbi.nlm.nih.gov
Objectives For revealing the peculiarities of the drug-drug interaction of rivaroxaban
(substrate CYP3A4 and P-gp) and calcium channel blockers (CCBs)(verapamil-inhibitor …